Skip to content

A study of patients with Parkinson's disease after COVID-19 infection

A study of patients with Parkinson's disease after COVID-19 infection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300069477
Enrollment
Unknown
Registered
2023-03-17
Start date
2023-03-17
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Group of Parkinson's disease:no

Sponsors

Beijing Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
40 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Aged 40-90 years, male and female; 2. Patients with primary PD met the clinical diagnostic criteria of PD MDS (2015); 3. The motor symptoms of PD were stable before infection with the novel coronavirus; 4. Understand and agree to follow the study protocol, agree to be enrolled and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Parkinsonian superposition and secondary parkinsonian syndroms, such as multiple system atrophy, progressive supranuclear palsy, cortical basal ganglia degeneration, lewy body dementia, vascular parkinsonian syndrome, postencephalitis parkinsonian syndrome, or any other non-primary parkinsonian disease; 2. With other serious diseases of nervous system or serious mental system diseases; In particular, they have severe cognitive dysfunction and cannot cooperate with researchers. 3. Could not cooperate with researchers; The researchers determined that patients were not suitable for inclusion.

Design outcomes

Primary

MeasureTime frame
motor and non-motor syndrome;

Countries

China

Contacts

Public ContactHouzhen Tuo

Beijing Friendship Hospital

tuohzh@sina.cn+86 13683628005

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026